Accelerated clinical development, enabled by global collaborations

Multiple assets in pre-clinical and clinical development

PRODUCT

INDICATIONS

 PRE-CLINICAL

          IIT

    PHASE 1/     PHASE 2

BRG01

First-in-Class

Nasopharyngeal cancer

EBV+ Hematologic malignancies

BST02

Best-in-Class

Liver cancer(all types)

BRL03

First-in-Class

Multiple solid tumors (incl. Lung)

BGT007

First-in-Class

CRC, GC, EC&PDAC

Multi-specific antibodies

First-in-Class

Multiple solid tumors

Allo-cel

First-in-Class

Multiple solid and liquid tumors